For a Brighter Future

Immunoglobulin Y (IgY) therapeutics to tackle infectious diseases
Biopharmaceuticals’ purification and stabilization
Get Started Contact Now

About us

RYAPURTECH is focused on the manufacturing and validation of Immunoglobulin Y (IgY) to tackle antibodies infectious diseases. Additional interests include the design of cost-effective pand validation of Immunoglobulin Y (IgY) antibodies to tackle infectious diseases. Additional interests include the design of cost-effective purification platforms and identification of alternative and effective stabilizers for other biopharmaceuticals.

RYAPURTECH owns the IP rights of a cost-effective purification platform to produce high quality and high purity IgY antibodies. The high yield and purity degree of our IgY antibodies allow their intravenous administration.
RYAPURTECH has extensive know-how to design novel cost-effective purification platforms and alternative stabilizers for a wide range of biopharmaceuticals. RYAPURTECH has equipped labs and the required conditions to work in the bioprocessing field.

developed a cost - effective and innovative purification platform to deliver high quality IgY antibodies with >98 % of purity

Latest News

centro 2020
portugal 2020
fundos europeus estruturais e de investimento
universidade de aveiro